Sorry, you need to enable JavaScript to visit this website.
Search
March 11, 2022

CDC-Abt Study Shows Pfizer Vaccine Is Moderately Effective for Children

Body

More than 300 news organizations, including CBS and Forbes, quoted Abt’s Lauren Olsho explaining the benefits of our PROTECT study for the CDC, which gathers and tests nasal swabs weekly from children, regardless of whether they had COVID-19 symptoms. “Without regular weekly testing you will miss many infections, particularly for kids, who often have mild symptoms,” said Olsho, the study’s principal investigator. Other pediatric vaccine studies captured only symptomatic cases, and with more home testing, studies like Abt’s are needed for a comprehensive view of vaccine effectiveness, she noted.

Read More

COVID-19 in North America

TSPi Enhances Customer Experience with Farmers.gov

The U.S. Department of Agriculture (USDA) faced the challenge of streamlining access to information, tools, and resources for farmers, ranchers, and landowners.

Learn More
Project

Housing California Annual Conference 2025

Join Abt Global and other leaders for the Housing California 2025 annual conference in Sacramento.

Learn More
Event

Human Trafficking Prevalence Estimation Feasibility Study

Abt developed a feasibility study to determine how the U.S. could pilot important data collection to assess national estimates of human trafficking. 

Learn More
Publication

Maternal Health in Rural America: Innovative Solutions

States and communities are developing and implementing innovative approaches to reduce the alarmingly high rate of preventable maternal deaths in the rural U.S.

Learn More
Blog